doi:10.1016/j.heliyon.2019.e02162
Computational approaches for clinical, genomic and proteomic markers of response to glucagon-like peptide-1 therapy in type-2 diabetes mellitus: an exploratory analysis with machine learning algorithms
Systemic MCAS Reactions: By "hiding" dietary proteins from hyperactive mast cells, targeted enzymes help reduce the likelihood of massive histamine dumps that cause systemic flushing, hives, itching, and sudden drops in blood pressure
GLP-1 receptor agonists have now established a role in the type 2 diabetes management algorithm as the preferred second-line agents in patients with known cardiovascular disease, heart failure, or chronic kidney disease, irrespective of baseline HbA1c
Han BI, Lee HW, Ryu S, Kim JS